Login / Signup

MEK Inhibitor-Associated Ocular Hypertension.

David A ColletJulia CanestraroGhassan K Abou-AlfaDavid H AbramsonEli L DiamondJasmine H Francis
Published in: Ocular oncology and pathology (2023)
This report presents 3 cases of elevated IOP in patients taking three distinct MEK inhibitors which would suggest that IOP-elevating effects exist across the class of MEK inhibitors. All 3 patients had a satisfactory response to topical pressure-lowering drops while continuing their life-preserving MEK inhibitor drug dose, indicating that discontinuation of therapy may not be necessary. Due to the increasing use of MEK inhibitors, it is important that ophthalmologists familiarize themselves with the broad range of potential adverse ocular effects of MEK inhibitors.
Keyphrases